Ask AI
ProCE Banner Activity

CROI 2026: A Patient Advocate's Perspective on Transformative Insights for HIV Care

Conference Coverage
Clinical Thought

The 33rd Conference on Retroviruses and Opportunistic Infections (CROI 2026) was a clarion call for advocates, healthcare professionals, and policymakers to unite in ensuring that the scientific advancements in HIV prevention and treatment reach those who need them most. Read on to learn how I, as a patient advocate, was inspired by the groundbreaking data presented at this conference, which highlighted not only advancements in prevention and treatment but also the pressing need for equitable access to these innovations. 

Released: March 26, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

Supported by independent educational grants from Gilead Sciences, Inc., Merck & Co., Inc., Rahway, NJ, USA, and ViiV Healthcare.

Gilead Sciences, Inc.

Merck & Co., Inc., Rahway, NJ, USA

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions

Disclosure

Primary Author

L. Lorenzo Williams has no relevant financial relationships to disclose.